Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
Date:2/27/2013

EXTON, Pa., Feb. 27, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) reported today its financial results for the fourth quarter and year ended December 31, 2012.

In 2012, we:

  • Achieved $428 million in annual net product sales, highlighted by $327 million in Worldwide net sales of Cinryze® (C1 esterase inhibitor [human]);
  • Generated net sales of approximately $17 million in Europe;
  • Attained GAAP net income of $6 million; and non-GAAP adjusted net income of $51 million;
  • Delivered positive cash flows from operations of $43 million;
  • Utilized $180 million of cash to repurchase approximately 7 million shares of ViroPharma stock; and
  • Finished the year with working capital of $339 million, including cash, cash equivalents and short-term investments of $247 million.

    • Net sales were $106.5 million and $427.9 million for the fourth quarter and year ended December 31, 2012, respectively, as compared to $145.6 million and $544.4 million in the comparative periods of 2011, respectively.  The decline in net sales quarter over quarter and year over year was driven as a result of the loss of Vancocin revenues partially offset by Cinryze growth. The 2012 U.S. Cinryze net sales of $320.6 million included approximately $311 million of patient demand.  The balance represented additional inventory in the channel. 

    "ViroPharma enters 2013 in a strong position to generate significant growth for years to come," stated Vincent Milano, ViroPharma's chief executive officer. "Cinryze in the U.S. continues to exceed our expectations, our products in Europe are beginning to demonstrate traction as we continue to expand those launches throughout the EU, the pipeline is more robust than it has ever been in our company's history and financially our company is in a very good position to remain opportun
    '/>"/>

    SOURCE ViroPharma Incorporated
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    2. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
    3. ViroPharma To Participate In The JMP Securities Healthcare Conference
    4. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
    5. ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
    6. ViroPharma Incorporated Reports Second Quarter 2012 Financial Results
    7. ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference
    8. ViroPharma To Host Analyst And Investor Seminar On September 21, 2012
    9. ViroPharma Incorporated Reports Third Quarter 2012 Financial Results
    10. ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
    11. ViroPharma To Participate In Two Upcoming Healthcare Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/20/2013)... WASHINGTON , May 20, 2013  Medicare ... networks are overwhelmingly satisfied, citing lower costs, convenient ... a new survey from Hart Research Associates released ... More than 40% of Part D seniors (9.5 ... networks. "Seniors like the lower costs, ...
    (Date:5/19/2013)... 2013  Whole-cell pertussis vaccines were more effective at ... large recent outbreak, according to a new Kaiser Permanente ... also called DTwP, were available from the 1940s to ... led to the development of acellular pertussis vaccines, which ... the United States had switched from ...
    (Date:5/17/2013)... -- The power of plants to cure and rejuvenate, ... depends on the plant kingdom, is the subject of ... Medicine: Healing Plants Around the World, Featuring ... 18 through September 8, 2013. (Photo:  ... attractions include a re-creation of the Western world,s oldest ...
    Breaking Medicine Technology:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2
    ... (OTC Bulletin Board: AEMD ), the pioneer ... and cancer, announced today that it has engaged Fabiani ... partnerships that advance biodefense, cancer, and chronic infectious disease ... the first medical device to selectively target the removal ...
    ... LAIYANG, China, Sept. 30 /PRNewswire-Asia-FirstCall/ -- ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
    Cached Medicine Technology:Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 2Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 3Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 4Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 5Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 2Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 3Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 4Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 5Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 6Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 7Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 8Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 9Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 10Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 11Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 12Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 13Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 14Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 15Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 16Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 17Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 18
    (Date:5/20/2013)... New York (PRWEB) May 20, 2013 National ... Firm P.A. and Thrash Law Firm P.A., both based in ... final approval of the proposed $7.25 billion settlement of a ... transaction fees. The objection was filed Wednesday, May 15, 2013, ... New York. The related lawsuit against Visa and MasterCard (Case ...
    (Date:5/20/2013)... is proud to announce the publication of the much-anticipated ... A. Weinberg. , The First Edition has been ... the most important advances in the fast-growing field of ... all of its hallmark features admired by students, instructors, ... of Cancer is a textbook for students studying the ...
    (Date:5/20/2013)... 2013 For more than forty years, ... battle against drug and alcohol abuse around the world. ... first guide to help Italian speakers reverse growing trends ... European Monitoring Centre for Drugs and Drug Addiction show ... cannabis in the last year. As a glimpse of ...
    (Date:5/20/2013)... -- A child whose mother lived near heavy traffic ... a respiratory infection before the age of 3, a ... nearly 1,300 pairs of mothers and infants from eastern ... their first trimester of pregnancy at some point between ... mothers lived within 100 meters (about 110 yards) from ...
    (Date:5/20/2013)... fossa subdural hematoma (PFSDH) is a serious and rare ... with appropriate treatment, there,s an excellent chance of good ... a study in the May issue of ... of Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , The results support ...
    Breaking Medicine News(10 mins):Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3Health News:'The Biology of Cancer' by Robert A. Weinberg 2Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3
    ... 11 private healthcare providers into the public NHS system thereby ... sector. //Mr Blair and the health secretary, Patricia Hewitt, welcomed ... to mark the launch of NHS Partners Network. ... towards 'future success' of the NHS. "Wherever people are treated ...
    ... are at a lesser risk of Parkinson’s, according to ... and Psychiatry. // ,The research team, as ... patients and 106 healthy people, belonging to the same ... sought to throw light on their personality traits and ...
    ... flu pandemic could claim as much as 140 million ... ,The authors of the report, internationally renowned ... academic Alexandra Sidorenko, estimate that even a mild pandemic ... economy $330 billion in lost production. ,The ...
    ... in Australia claims to have discovered a novel way ... attention deficit hyperactivity disorder (ADHD). //This novel method, space-age ... space. But it can also be used by the ... , ,Attention deficit hyperactivity disorder (ADHD) is a ...
    ... firm LG Electronics has said that it will start to ... filter made from using an enzyme contained in the "the ... against the dreaded bird flu virus. ,"We developed ... flu," LG spokeswoman Park Se-won said. The filter was fabricated ...
    ... are pushing Wal-Mart against a Wall, to cough up more on ... the unions are doing this for the cause of the workers, ... meets the eye. The scene is on the brink of a ... ,The scene at Washington is hotting up with the ...
    Cached Medicine News:
    Compact, bench-top analyser with minimal water volume requirements and easy waste management....
    ... source is a superior choice for machine ... headlamps, and dental curing. This is a ... weight, compact and cost competitve with lower ... source utilizes the latest in Cermax technology, ...
    ... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...
    ... 350 Chemistry System offers easy operation, maintenance, and ... STAT, or back-up to the powerful VITROS 5,1 ... the job done right the first time. Its ... are efficient, dependable, and easy-to-use. The VITROS 350 ...
    Medicine Products: